Skip to main content
Top
Published in: BMC Public Health 1/2022

Open Access 01-12-2022 | Vaccination | Research article

An innovative approach in monitoring oral cholera vaccination campaign: integration of a between-round survey

Authors: Jerôme Ateudjieu, Martin Ndinakie Yakum, André Pascal Goura, Maureen Tembei Ayok, Etienne Guenou, Corine Blondo Kangmo Sielinou, Frank Forex Kiadjieu, Marcellin Tsafack, Ingrid Marcelle Douanla Koutio, Ketina Hirma Tchio-Nighie, Hervé Tchokomeni, Paul Nyibio Ntsekendio , David A. Sack

Published in: BMC Public Health | Issue 1/2022

Login to get access

Abstract

Background

Monitoring and Evaluation (M&E) is essential in ensuring population’s access to immunization. Surveys are part of this M&E approach but its timing limits the use of its results to improve the coverage of the evaluated campaign. An oral cholera vaccination campaign was organized in a health district of the Far North region of Cameroon and involved an innovative M&E approach. The aim of this project was to assess the feasibility and effect of using recommendations of a community-based immunization and communication coverage survey conducted after the first round of an OCV campaign on the coverage of the second-round of the campaign.

Methods

Two community-based surveys were included in the M&E plan and conducted at the end of each of the campaign rounds. Data were collected by trained and closely supervised surveyors and reported using smartphones. Key results of the first-round survey were disseminated to campaign implementing team prior to the second round. The two rounds of the pre-emptive campaign were organized by the Cameroon Ministry of Public Health and partners with a two-week interval in the Mogode Health District of the Far North region of Cameroon in May and June 2017.

Results

Of 120 targeted clusters, 119 (99.1%) and 117 (97.5%) were reached for the first and second rounds respectively. Among the Mogode population eligible for vaccination, the immunization coverage based on evidence (card or finger mark) were estimated at 81.0% in the first round and increased to 88.8% in the second round (X2=69.0 and p <0.00). For the second round, we estimated 80.1% and 4.3% of persons who were administered 2 doses and 1 dose of OCV with evidence respectively, and 3.8% of persons who have not been vaccinated. The distribution of campaign communication coverage per health area was shared with the campaign coordination team for better planning of the second round campaign activities.

Conclusions

It is feasible to plan and implement coverage survey after first round OCV campaign and use its results for the better planning of the second round. For the present study, this is associated to the improvement of OCV coverage in the second-round vaccination. If this is persistent in other contexts, it may apply to improve coverage of any health campaign that is organized in more than one round.
Appendix
Available only for authorised users
Literature
7.
go back to reference Hsiao A, Desai SN, Mogasale V, Excler J-L, Digilio L. Lessons learnt from 12 oral cholera vaccine campaigns in resource-poor settings. Bull World Health Organ. 2017 Apr;95(4)(1):303–12.CrossRef Hsiao A, Desai SN, Mogasale V, Excler J-L, Digilio L. Lessons learnt from 12 oral cholera vaccine campaigns in resource-poor settings. Bull World Health Organ. 2017 Apr;95(4)(1):303–12.CrossRef
8.
go back to reference Legros D, Paquet C, Perea W, Marty I, Mugisha NK, Royer H, et al. Mass vaccination with a two-dose oral cholera vaccine in a refugee camp. Bull World Health Organ. 1999;77(10):837–42.PubMedPubMedCentral Legros D, Paquet C, Perea W, Marty I, Mugisha NK, Royer H, et al. Mass vaccination with a two-dose oral cholera vaccine in a refugee camp. Bull World Health Organ. 1999;77(10):837–42.PubMedPubMedCentral
10.
go back to reference Ferreras E, Matapo B, Chizema-Kawesha E, Chewe O, Mzyece H, Blake A, et al. Delayed second dose of oral cholera vaccine administered before high-risk period for cholera transmission: Cholera control strategy in Lusaka, 2016. PloS One. 2019;14(8):e0219040.CrossRef Ferreras E, Matapo B, Chizema-Kawesha E, Chewe O, Mzyece H, Blake A, et al. Delayed second dose of oral cholera vaccine administered before high-risk period for cholera transmission: Cholera control strategy in Lusaka, 2016. PloS One. 2019;14(8):e0219040.CrossRef
11.
12.
go back to reference Massing La, Aboubakar S, Blake A, Page Al, Cohuet S, Ngandwe A, et al. Highly targeted cholera vaccination campaigns in urban setting are feasible: The experience in Kalemie, Democratic Republic of Congo. PLoS Negl Trop Dis [Internet]. 2018 Jul 5 [cited 2021 Jun 7];12(5). Available from: https://pubmed.ncbi.nlm.nih.gov/29734337/. Massing La, Aboubakar S, Blake A, Page Al, Cohuet S, Ngandwe A, et al. Highly targeted cholera vaccination campaigns in urban setting are feasible: The experience in Kalemie, Democratic Republic of Congo. PLoS Negl Trop Dis [Internet]. 2018 Jul 5 [cited 2021 Jun 7];12(5). Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​29734337/​.
17.
go back to reference Oh DH, Dabbagh A, Goodson JL, Strebel PM, Thapa S, Giri JN, et al. Real-Time Monitoring of Vaccination Campaign Performance Using Mobile Phones - Nepal, 2016. MMWR Morb Mortal Wkly Rep. 2016 Oct 7;65(39):1072–6. Oh DH, Dabbagh A, Goodson JL, Strebel PM, Thapa S, Giri JN, et al. Real-Time Monitoring of Vaccination Campaign Performance Using Mobile Phones - Nepal, 2016. MMWR Morb Mortal Wkly Rep. 2016 Oct 7;65(39):1072–6.
18.
go back to reference Semá Baltazar C, Rafael F, Langa Jpm, Chicumbe S, Cavailler P, Gessner, Bd, et al. Oral cholera vaccine coverage during a preventive door-to-door mass vaccination campaign in Nampula, Mozambique. PloS One [Internet]. 2018 Mar 10 [cited 2021 Jun 7];13(10). Available from: https://pubmed.ncbi.nlm.nih.gov/30281604/. Semá Baltazar C, Rafael F, Langa Jpm, Chicumbe S, Cavailler P, Gessner, Bd, et al. Oral cholera vaccine coverage during a preventive door-to-door mass vaccination campaign in Nampula, Mozambique. PloS One [Internet]. 2018 Mar 10 [cited 2021 Jun 7];13(10). Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​30281604/​.
19.
go back to reference Luquero FJ, Grout L, Ciglenecki I, Sakoba K, Traore B, Heile M, et al. First Outbreak Response Using an Oral Cholera Vaccine in Africa: Vaccine Coverage, Acceptability and Surveillance of Adverse Events, Guinea, 2012. PLoS Negl Trop Dis. 2013;17(10):e2465.CrossRef Luquero FJ, Grout L, Ciglenecki I, Sakoba K, Traore B, Heile M, et al. First Outbreak Response Using an Oral Cholera Vaccine in Africa: Vaccine Coverage, Acceptability and Surveillance of Adverse Events, Guinea, 2012. PLoS Negl Trop Dis. 2013;17(10):e2465.CrossRef
21.
go back to reference Martínez-Mesa J, González-Chica DA, Bastos JL, Bonamigo RR, Duquia RP. Sample size: how many participants do I need in my research? An Bras Dermatol. 2014;89(4):609–15.CrossRef Martínez-Mesa J, González-Chica DA, Bastos JL, Bonamigo RR, Duquia RP. Sample size: how many participants do I need in my research? An Bras Dermatol. 2014;89(4):609–15.CrossRef
23.
go back to reference Sur D, Kanungo S, Sah B, Manna B, Ali M, Paisley AM, et al. Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial. PLoS Negl Trop Dis. 2011;5(10):e1289.CrossRef Sur D, Kanungo S, Sah B, Manna B, Ali M, Paisley AM, et al. Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial. PLoS Negl Trop Dis. 2011;5(10):e1289.CrossRef
26.
go back to reference Bi Q, Ferreras E, Pezzoli L, Legros D, Ivers LC, Date K, et al. Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2017;17(10):1080–8.CrossRef Bi Q, Ferreras E, Pezzoli L, Legros D, Ivers LC, Date K, et al. Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2017;17(10):1080–8.CrossRef
31.
go back to reference Wallace A, Dietz V, Cairns KL. Integration of immunization services with other health interventions in the developing world: what works and why? Systematic literature review. Trop Med Int Health TM IH. 2009;14(1):11–9.CrossRef Wallace A, Dietz V, Cairns KL. Integration of immunization services with other health interventions in the developing world: what works and why? Systematic literature review. Trop Med Int Health TM IH. 2009;14(1):11–9.CrossRef
32.
go back to reference Pezzoli L, Conteh I, Kamara W, Gacic-Dobo M, Ronveaux O, Perea WA, et al. Intervene before leaving: clustered lot quality assurance sampling to monitor vaccination coverage at health district level before the end of a yellow fever and measles vaccination campaign in Sierra Leone in 2009. BMC Public Health. 2012 Jun 7;12:415. Pezzoli L, Conteh I, Kamara W, Gacic-Dobo M, Ronveaux O, Perea WA, et al. Intervene before leaving: clustered lot quality assurance sampling to monitor vaccination coverage at health district level before the end of a yellow fever and measles vaccination campaign in Sierra Leone in 2009. BMC Public Health. 2012 Jun 7;12:415.
35.
go back to reference Schaetti C, Ali SM, Hutubessy R, Khatib AM, Chaignat C-L, Weiss MG. Social and cultural determinants of oral cholera vaccine uptake in Zanzibar. Hum Vaccines Immunother. 2012;8(9):1223–9.CrossRef Schaetti C, Ali SM, Hutubessy R, Khatib AM, Chaignat C-L, Weiss MG. Social and cultural determinants of oral cholera vaccine uptake in Zanzibar. Hum Vaccines Immunother. 2012;8(9):1223–9.CrossRef
36.
go back to reference Schwerdtle P, Onekon C-K, Recoche K. A Quantitative Systematic Review and Meta-Analysis of the Effectiveness of Oral Cholera Vaccine as a Reactive Measure in Cholera Outbreaks. Prehospital Disaster Med. 2018;33(1):2–6.CrossRef Schwerdtle P, Onekon C-K, Recoche K. A Quantitative Systematic Review and Meta-Analysis of the Effectiveness of Oral Cholera Vaccine as a Reactive Measure in Cholera Outbreaks. Prehospital Disaster Med. 2018;33(1):2–6.CrossRef
38.
go back to reference Joe P, Majgi SM, Vadiraja N, Khan MA. Influence of Sociodemographic Factors in Measles-Rubella Campaign Compared with Routine Immunization at Mysore City. Indian J Community Med Off Publ Indian Assoc Prev Soc Med. 2019;44(3):209–12. Joe P, Majgi SM, Vadiraja N, Khan MA. Influence of Sociodemographic Factors in Measles-Rubella Campaign Compared with Routine Immunization at Mysore City. Indian J Community Med Off Publ Indian Assoc Prev Soc Med. 2019;44(3):209–12.
40.
go back to reference Démolis R, Botão C, Heyerdahl LW, Gessner BD, Cavailler P, Sinai C, et al. A rapid qualitative assessment of oral cholera vaccine anticipated acceptability in a context of resistance towards cholera intervention in Nampula, Mozambique. Vaccine. 2018;22(44):6497–505.CrossRef Démolis R, Botão C, Heyerdahl LW, Gessner BD, Cavailler P, Sinai C, et al. A rapid qualitative assessment of oral cholera vaccine anticipated acceptability in a context of resistance towards cholera intervention in Nampula, Mozambique. Vaccine. 2018;22(44):6497–505.CrossRef
Metadata
Title
An innovative approach in monitoring oral cholera vaccination campaign: integration of a between-round survey
Authors
Jerôme Ateudjieu
Martin Ndinakie Yakum
André Pascal Goura
Maureen Tembei Ayok
Etienne Guenou
Corine Blondo Kangmo Sielinou
Frank Forex Kiadjieu
Marcellin Tsafack
Ingrid Marcelle Douanla Koutio
Ketina Hirma Tchio-Nighie
Hervé Tchokomeni
Paul Nyibio Ntsekendio
David A. Sack
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2022
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-022-12610-5

Other articles of this Issue 1/2022

BMC Public Health 1/2022 Go to the issue